Coya Therapeutics (COYA) Non-Current Deffered Revenue (2023 - 2025)
Historic Non-Current Deffered Revenue for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to $1.1 million.
- Coya Therapeutics' Non-Current Deffered Revenue fell 1074.18% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 1074.18%. This contributed to the annual value of $945447.0 for FY2024, which is 6451.57% up from last year.
- According to the latest figures from Q3 2025, Coya Therapeutics' Non-Current Deffered Revenue is $1.1 million, which was down 1074.18% from $641158.0 recorded in Q2 2025.
- Over the past 5 years, Coya Therapeutics' Non-Current Deffered Revenue peaked at $1.2 million during Q3 2024, and registered a low of $574685.0 during Q4 2023.
- In the last 3 years, Coya Therapeutics' Non-Current Deffered Revenue had a median value of $775542.5 in 2024 and averaged $838440.6.
- As far as peak fluctuations go, Coya Therapeutics' Non-Current Deffered Revenue surged by 6451.57% in 2024, and later plummeted by 2515.52% in 2025.
- Coya Therapeutics' Non-Current Deffered Revenue (Quarter) stood at $574685.0 in 2023, then surged by 64.52% to $945447.0 in 2024, then grew by 15.42% to $1.1 million in 2025.
- Its Non-Current Deffered Revenue was $1.1 million in Q3 2025, compared to $641158.0 in Q2 2025 and $694435.0 in Q1 2025.